- Home
- PYXS vs NCSM Comparison
PYXS vs NCSM Comparison
Compare PYXS & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYXS
- NCSM
- Stock Information
- Founded
- PYXS 2018
- NCSM 2006
- Country
- PYXS United States
- NCSM United States
- Employees
- PYXS N/A
- NCSM N/A
- Industry
- PYXS Biotechnology: Pharmaceutical Preparations
- NCSM Oilfield Services/Equipment
- Sector
- PYXS Health Care
- NCSM Energy
- Exchange
- PYXS Nasdaq
- NCSM Nasdaq
- Market Cap
- PYXS 75.0M
- NCSM 76.3M
- IPO Year
- PYXS 2021
- NCSM 2017
- Fundamental
- Price
- PYXS $1.10
- NCSM $31.64
- Analyst Decision
- PYXS Strong Buy
- NCSM
- Analyst Count
- PYXS 5
- NCSM 0
- Target Price
- PYXS $9.00
- NCSM N/A
- AVG Volume (30 Days)
- PYXS 387.8K
- NCSM 4.1K
- Earning Date
- PYXS 08-13-2025
- NCSM 07-31-2025
- Dividend Yield
- PYXS N/A
- NCSM N/A
- EPS Growth
- PYXS N/A
- NCSM N/A
- EPS
- PYXS N/A
- NCSM 4.71
- Revenue
- PYXS N/A
- NCSM $175,468,000.00
- Revenue This Year
- PYXS N/A
- NCSM $7.17
- Revenue Next Year
- PYXS N/A
- NCSM $5.44
- P/E Ratio
- PYXS N/A
- NCSM $6.72
- Revenue Growth
- PYXS N/A
- NCSM 19.31
- 52 Week Low
- PYXS $0.83
- NCSM $16.66
- 52 Week High
- PYXS $5.39
- NCSM $38.95
- Technical
- Relative Strength Index (RSI)
- PYXS 43.52
- NCSM 58.61
- Support Level
- PYXS $1.12
- NCSM $29.92
- Resistance Level
- PYXS $1.38
- NCSM $30.85
- Average True Range (ATR)
- PYXS 0.08
- NCSM 0.90
- MACD
- PYXS -0.01
- NCSM 0.11
- Stochastic Oscillator
- PYXS 5.08
- NCSM 43.59
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.